Aligos Therapeutics, Inc.

Aligos Therapeutics, Inc.

ALGS
Aligos Therapeutics, Inc.US flagNASDAQ Global Select
5.44
USD
+0.16
- -
33.66MMarket Cap

Aligos Therapeutics, Inc. (ALGS) Stock Split History

Learn about Aligos Therapeutics, Inc.'s most recent 1-for-25 basis stock split on August 19, 2024. Understand the impact on shareholders and the company's market position.

APIChatGPT

Latest Stock Split Details

Key information about Aligos Therapeutics, Inc.'s most recent stock split

Split Date: 2024-08-19
Split Ratio: 1:25
Price Before Split: $0.57
Price After Split: $0.02

Developer API

Get ALGS split history as JSON

Dates, ratios, split factors, and pre/post-split prices from a single REST call. Look up by ticker, CIK, CUSIP, or ISIN. Free tier, no scraping.

GETapi.roic.ai/v2/stock-splits/ALGS

Impact of the Stock Split

Understanding what this means for shareholders

  • The total value of your investment remains the same
  • You now own 25.00 times fewer shares (a 1:25 ratio)
  • The price per share is increased proportionally

Historical Stock Splits

A comprehensive history of Aligos Therapeutics, Inc.'s stock splits

DateRatioIs Reverse SplitPrice Before SplitPrice After Split
2024-08-191:25Yes$0.57$0.02

About Aligos Therapeutics, Inc.

Company overview and industry information

Aligos Therapeutics, Inc. (ALGS) operates in the Biotechnology industry. The recent 1-for-25 reverse stock split is part of the company's strategy to adjust its share price and potentially meet stock exchange listing requirements.

Biotechnology
Go to Aligos Therapeutics, Inc. Summary

Last updated: 7/22/2026

This information is for educational purposes only. Always consult with a financial advisor before making investment decisions.